Bioject Medical Technologies Inc. Enters Into Three Distribution Agreements

TIGARD, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTC Pink: BJCT), a developer and manufacturer of needle-free injection therapy systems, today announced that it has entered into three international distribution agreements, two in the Pacific Rim region and one in the Middle East. The agreements call for the sale of the Biojector®2000 gas-powered device, the Bioject® ZetaJet™ spring-powered device and accessories through qualified medical device groups located in Australia, the Republic of the Philippines, and North Africa. The agreements provide for distribution in multiple territories throughout the regions.